Detection of bony metastases of androgen-independent prostate cancer by PET-FDG

Adler, 1991, Noninvasive grading of musculoskeletal tumor using PET, J. Nucl. Med., 32, 1508 Di Chiro, 1987, Positron emission tomography using PET-fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool, Invest. Radiol., 22, 360, 10.1097/00004424-198705000-00002 Fukuda, 1994, A case of hepatocellular carcinoma with lumbar metastases with high uptake of 18-F fluorodeoxyglucose in PET, Jp. J. Nucl. Med., 31, 1351 Galasko, 1995, Diagnosis of skeletal metastases and assessment of response to treatment, Clin. Orthop., 312, 64 Gupta, 1992, Solitary pulmonary nodules: Detection of malignancies with PET with 2 F-18 fluoro-2-deoxy-d-glucose, Radiology, 184, 441, 10.1148/radiology.184.2.1620844 Hoffman, 1993, FDG-PET evaluation of vertebral compression fracture in cancer patients, J. Nucl. Med., 34, 7P Hoh, 1993, Cancer detection with whole body PET using 18-F fluoro-deoxyglucose, J. Comput. Assist. Tomogr., 17, 582, 10.1097/00004728-199307000-00012 Hosokawa, 1994, Usefulness of 99-Tc-PMT SPECT and 18-F-FDG PET in diagnosing orbital metastases of hepatocellular carcinoma, Jp. J. Nucl. Med., 31, 1237 Hubner, 1995, Characterization of chest masses by FDG-PET, Clin. Nucl. Med., 20, 293, 10.1097/00003072-199504000-00001 Jorgens, 1968, The radiographic characteristics of carcinoma of the prostate, Surg. Clin. North Am., 45, 1427, 10.1016/S0039-6109(16)37733-7 Kalkner, 1995, Somatostatin receptor scintigraphy in metastatic hormone refractory prostatic carcinoma, Antib. Immun. Radiopharm., 8, 11 Kontsilieris, 1995, Skeletal metastasis in advanced prostate carcinoma: Cell biology and therapy, Crit. Rev. Oncol. Hematol., 18, 51, 10.1016/1040-8428(94)00122-A Kozlowsky, 1991, Advanced prostatic carcinoma—early versus late endocrine therapy, Urol. Clin. North Am., 18, 15, 10.1016/S0094-0143(21)01389-6 Larson, 1994, Advances in imaging, 21, 598 Levenson, 1983, Comparative value of bony scintigraphy and radiography in monitoring tumor response in systematically treated prostatic carcinoma, Radiology, 146, 513, 10.1148/radiology.146.2.6294738 Mettlin, 1993, Trends in prostate cancer care in the United States, 1974–1990: Observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer, CA Cancer J. Clin., 43, 83, 10.3322/canjclin.43.2.83 Minn, 1992, Cancer treatment monitoring with fluorine-18-2-fluoro-2-deoxyglucose and positron emission tomography: Frustration or future, Eur. J. Nucl. Med., 19, 921, 10.1007/BF00175856 Minn, 1989, 18F-Fluorodeoxyglucose scintigraphy in diagnosis and follow-up of treatment in advanced breast cancer, Eur. J. Nucl. Med., 15, 61, 10.1007/BF00702620 Nilsson, 1995, 11-C Methionine positron emission tomography in the management of prostatic carcinoma, Antib. Immun. Radiopharm., 8, 23 Orr, 1995, Tumor-bone interactions in skeletal metastases, Clin Orthop., 312, 19 Patronas, 1985, Prediction of survival in glioma patients by means of positron emission tomography, Neurosurgery, 62, 816, 10.3171/jns.1985.62.6.0816 Pollen, 1979, Osteoblastic response to successful treatment of metastatic cancer of the prostate, Am. J. Radiol., 132, 927 Ponto, 1995, Standardized uptake values (SUV) for F-18 FDG in normal tissues, J. Nucl. Med., 36, 165P Sasaki, 1993, Fluorine- 18-fluorodeoxyglucose positron emission tomography in Tc99m-MDP negative bone tumors, J. Nucl. Med., 34, 288 Scher, 1994, Bone metastases: Improving the therapeutic index, 21, 630 Shelton, 1995, Diagnosis of bone metastases in lung cancer by whole-body PET-FDG imaging: Comparison to conventional skeletal scintigraphy, J. Nucl. Med., 36, 200P Shreve, 1995, Detection of prostate cancer metastases with PET-FDG, J. Nucl. Med., 36, 189P Shreve, 1993, Initial assessment of FDG/PET detection of skeletal metastatic prostate carcinoma, J. Nucl. Med., 34, 223P Srrauss, 1989, Recurrence of colorectal tumors: PET evaluation, Radiology, 170, 329, 10.1148/radiology.170.2.2783494 Volk, 1988, PET of malignant cerebral tumors after interstitial brachytherapy, J. Neurosurg., 69, 830, 10.3171/jns.1988.69.6.0830 Wahl, 1991, Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analog F-18 fluoro-2-deoxyglucose, Radiology, 179, 765, 10.1148/radiology.179.3.2027989 Wingo, 1995, Cancer statistics, 1995, CA Cancer J. Clin., 45, 8, 10.3322/canjclin.45.1.8 Yeh, 1980, Fluorine-18 positron emission tomography of bone lesions, J. Nucl. Med., 21, 56P